Company signals · Biotech & Pharma
AusBiotech
1 signal in the current window, with MitchelLake's leadership read on each.
Market context: MitchelLake's Talent Market Index sits at 110 (Hot), up 11.7 on the prior month; Oceania hiring signal is running rising (+7.7pts).
AusBiotech: 1 signal in the last 90 days — in line with the Biotech & Pharma median of 1 across 21 tracked companies; 0.1% of MitchelLake's Oceania signal flow.
Signals at AusBiotech
More signals across Biotech & Pharma
Ma Activity · Oceania
UCB →UCB acquiring Neurona Therapeutics for $650M plus up to $500M in milestones to expand epilepsy portfolio
Partnership · Americas
Ratio Therapeutics →Ratio Therapeutics expanded manufacturing collaboration with PharmaLogic to add capacity and redundancy for clinical development of lead radiotherapeutic candidate BOSTON
Partnership · Americas
Bristol Myers Squibb →Bristol Myers Squibb entered into a major alliance with Chinese pharmaceutical firm Hengrui involving up to 13 drugs and valued at up to $15.2 billion. This represents significant international collaboration in drug development and commercialization.
Partnership · Americas
BioDuro →BioDuro forms strategic partnership with CTI Biotechnology to create integrated platform from discovery to IND submission for preclinical drug development
Partnership · EMEA
Thermo Fisher Scientific →Thermo Fisher Scientific awarded UK government contract: "Supply of 2 Ion Chromatography systems" — buyer: Nuclear Restoration Services Limited
Product Launch · Americas
Neurocrine Biosciences →Neurocrine presented CRENESSITY clinical data at ENDO 2026 demonstrating hormone normalization in classic CAH and two-year cardiometabolic and bone health outcomes in adults.
Intelligence powered by Autonodal ↗